BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20070029)

  • 1. Nuclear receptors gene polymorphisms and risk of restenosis and clinical events following coronary stenting.
    Neugebauer P; Goldbergová-Pávková M; Kala P; Bocek O; Jerábek P; Poloczek M; Vytiska M; Parenica J; Mikulík R; Jarkovský J; Semrád B; Spinar J; Vasků A
    Vnitr Lek; 2009 Dec; 55(12):1135-40. PubMed ID: 20070029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma and interferon-gamma receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting.
    Tiroch K; von Beckerath N; Koch W; Lengdobler J; Joost A; Schömig A; Kastrati A
    Atherosclerosis; 2005 Sep; 182(1):145-51. PubMed ID: 16115485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.
    Böttiger C; Koch W; Lahn C; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Am Heart J; 2003 Nov; 146(5):855-61. PubMed ID: 14597935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting.
    Tiroch K; Koch W; von Beckerath N; Kastrati A; Schömig A
    Eur Heart J; 2007 Apr; 28(8):968-73. PubMed ID: 17400606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T29C (rs1800470) polymorphism of the transforming growth factor-β1 (TGF-β1) gene is associated with restenosis after coronary stenting in Mexican patients.
    Fragoso JM; Zuñiga-Ramos J; Arellano-González M; Alvarez-León E; Villegas-Torres BE; Cruz-Lagunas A; Delgadillo-Rodriguez H; Peña-Duque MA; Martínez-Ríos MA; Vargas-Alarcón G
    Exp Mol Pathol; 2015 Feb; 98(1):13-7. PubMed ID: 25449332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients.
    Miranda-Malpica E; Martínez-Rios MA; Fragoso JM; Delgadillo-Rodríguez H; Rodríguez-Pérez JM; González-Quesada C; Martínez-Rodríguez N; Saldaña-Mendoza A; Peña-Duque MA; Vargas-Alarcón G
    Hum Immunol; 2008 Feb; 69(2):116-21. PubMed ID: 18361937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population.
    Shim CY; Park S; Yoon SJ; Park HY; Kim HT; Oh B; Park C; Ko YG; Choi D; Jang Y; Chung N
    Cardiology; 2007; 107(4):261-8. PubMed ID: 16954682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5A/6A polymorphism of the stromelysin-1 gene and angiographic restenosis after coronary artery stenting.
    Chiou KR; Chung SL; Charng MJ
    J Chin Med Assoc; 2005 Nov; 68(11):506-12. PubMed ID: 16323393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting.
    Koch W; Tiroch K; von Beckerath N; Schömig A; Kastrati A
    Cytokine; 2003 Nov; 24(4):161-71. PubMed ID: 14572794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
    Szeto CC; Chow KM; Poon PY; Kwan BC; Li PK
    Am J Nephrol; 2008; 28(5):715-22. PubMed ID: 18417957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting.
    Koch W; Böttiger C; Mehilli J; von Beckerath N; Neumann FJ; Schömig A; Kastrati A
    Am J Cardiol; 2001 Nov; 88(10):1120-4. PubMed ID: 11703955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting.
    Pesonen U; Koch W; Schömig A; Kastrati A
    J Endovasc Ther; 2003 Jun; 10(3):566-72. PubMed ID: 12932169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.
    Qian Y; Li P; Zhang J; Shi Y; Chen K; Yang J; Wu Y; Ye X
    Medicine (Baltimore); 2016 Aug; 95(32):e4299. PubMed ID: 27512842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis.
    Gomma AH; Elrayess MA; Knight CJ; Hawe E; Fox KM; Humphries SE
    Eur Heart J; 2002 Dec; 23(24):1955-62. PubMed ID: 12473258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis.
    Ryu SK; Cho EY; Park HY; Im EK; Jang YS; Shin GJ; Shim WH; Cho SY
    Yonsei Med J; 2002 Aug; 43(4):461-72. PubMed ID: 12205735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions.
    Hoppmann P; Koch W; Schömig A; Kastrati A
    Eur Heart J; 2004 Feb; 25(4):335-41. PubMed ID: 14984923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
    Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
    J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in peroxisome proliferator-activated receptor-γ and retinoid X receptor-α gene and type 2 diabetes risk: a case-control study of a Chinese Han population.
    Lu Y; Ye X; Cao Y; Li Q; Yu X; Cheng J; Gao Y; Ma J; Du W; Zhou L
    Diabetes Technol Ther; 2011 Feb; 13(2):157-64. PubMed ID: 21284483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting.
    Chen YH; Chau LY; Lin MW; Chen LC; Yo MH; Chen JW; Lin SJ
    Eur Heart J; 2004 Jan; 25(1):39-47. PubMed ID: 14683741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.
    Humphries S; Bauters C; Meirhaeghe A; Luong L; Bertrand M; Amouyel P
    Eur Heart J; 2002 May; 23(9):721-5. PubMed ID: 11977998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.